keyword
https://read.qxmd.com/read/38613076/association-between-daily-dietary-calcium-intake-and-the-risk-of-cardiovascular-disease-cvd-in-postmenopausal-korean-women
#21
JOURNAL ARTICLE
Jae Kyung Lee, Thi Minh Chau Tran, Euna Choi, Jinkyung Baek, Hae-Rim Kim, Heeyon Kim, Bo Hyon Yun, Seok Kyo Seo
We aimed to evaluate the association between daily dietary calcium intake and the risk of cardiovascular disease (CVD) in postmenopausal women using data from the Korean National Health and Nutrition Examination Survey (KNHANES). This cross-sectional study included 12,348 women aged 45-70 years who had reached natural menopause. They were classified into three groups according to daily dietary calcium intake: <400 mg, 400-800 mg, and >800 mg. The risks of CVD, stroke, angina, and myocardial infarction were assessed in each group...
April 3, 2024: Nutrients
https://read.qxmd.com/read/38613031/calorie-restriction-using-high-fat-low-carbohydrate-diet-suppresses-liver-fat-accumulation-and-pancreatic-beta-cell-dedifferentiation-in-obese-diabetic-mice
#22
JOURNAL ARTICLE
Xiao Lei, Emi Ishida, Satoshi Yoshino, Shunichi Matsumoto, Kazuhiko Horiguchi, Eijiro Yamada
In diabetes, pancreatic β-cells gradually lose their ability to secrete insulin with disease progression. β-cell dysfunction is a contributing factor to diabetes severity. Recently, islet cell heterogeneity, exemplified by β-cell dedifferentiation and identified in diabetic animals, has attracted attention as an underlying molecular mechanism of β-cell dysfunction. Previously, we reported β-cell dedifferentiation suppression by calorie restriction, not by reducing hyperglycemia using hypoglycemic agents (including sodium-glucose cotransporter inhibitors), in an obese diabetic mice model ( db / db )...
March 28, 2024: Nutrients
https://read.qxmd.com/read/38612993/association-of-gut-microbiota-related-metabolites-and-type-2-diabetes-in-two-puerto-rican-cohorts
#23
JOURNAL ARTICLE
Caleigh M Sawicki, Lorena S Pacheco, Sona Rivas-Tumanyan, Zheyi Cao, Danielle E Haslam, Liming Liang, Katherine L Tucker, Kaumudi Joshipura, Shilpa N Bhupathiraju
(1) Aims: Gut microbiota metabolites may play integral roles in human metabolism and disease progression. However, evidence for associations between metabolites and cardiometabolic risk factors is sparse, especially in high-risk Hispanic populations. We aimed to evaluate the cross-sectional and longitudinal relationships between gut microbiota related metabolites and measures of glycemia, dyslipidemia, adiposity, and incident type 2 diabetes in two Hispanic observational cohorts. (2) Methods: We included data from 670 participants of the Boston Puerto Rican Health Study (BPRHS) and 999 participants of the San Juan Overweight Adult Longitudinal Study (SOALS)...
March 27, 2024: Nutrients
https://read.qxmd.com/read/38612504/underlying-mechanisms-behind-the-brain-gut-liver-axis-and-metabolic-associated-fatty-liver-disease-mafld-an-update
#24
REVIEW
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, Adriano Cressoni Araújo, Ricardo de Alvares Goulart, Marcelo Dib Bechara, Lucas Fornari Laurindo, Nahum Méndez-Sánchez, Sandra Maria Barbalho
Metabolic-associated fatty liver disease (MAFLD) includes several metabolic dysfunctions caused by dysregulation in the brain-gut-liver axis and, consequently, increases cardiovascular risks and fatty liver dysfunction. In MAFLD, type 2 diabetes mellitus, obesity, and metabolic syndrome are frequently present; these conditions are related to liver lipogenesis and systemic inflammation. This study aimed to review the connection between the brain-gut-liver axis and MAFLD. The inflammatory process, cellular alterations in hepatocytes and stellate cells, hypercaloric diet, and sedentarism aggravate the prognosis of patients with MAFLD...
March 26, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38609038/deciphering-the-molecular-pathways-of-saroglitazar-a-dual-ppar-%C3%AE-%C3%AE-agonist-for-managing-metabolic-nafld
#25
REVIEW
Devaraj Ezhilarasan
Saroglitazar (SARO), a dual peroxisome proliferator activated receptor (PPAR)-α/γ agonist, has been used to treat metabolic diseases such as insulin resistance and diabetic dyslipidemia in patients with non-alcoholic fatty liver disease (NAFLD). SARO, administered at a dose of 4 mg/day, has been consistently studied in clinical trials with different time points ranging from 4 to 24 weeks with NAFLD patients. Due to its PPAR-γ agonistic action, SARO prevents adipose tissue-mediated fatty acid delivery to the liver by increasing insulin sensitivity and regulating adiponectin and leptin levels in adipose tissue...
April 10, 2024: Metabolism: Clinical and Experimental
https://read.qxmd.com/read/38607342/the-association-of-self-reported-sleep-and-circadian-measures-with-glycemic-control-and-diabetes-complications-among-young-adults-with-type-2-diabetes
#26
JOURNAL ARTICLE
Dorit Koren, Kristen L Knutson, Brian K Burke, Kimberly L Drews, Fida Bacha, Lorraine Katz, Marsha D Marcus, Siripoom McKay, Kristen Nadeau, Babak Mokhlesi
We aim to examine the association of sleep duration, sleep quality, late chronotype and circadian misalignment with glycemic control and risk of complications in young adults with youth-onset type 2 diabetes followed in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study. Self-reported sleep duration, quality, timing, and circadian misalignment were assessed via a modified Pittsburgh Sleep Quality Index (PSQI) questionnaire, and chronotype was assessed via the Morningness-Eveningness Questionnaire (MEQ)...
April 12, 2024: American Journal of Physiology. Heart and Circulatory Physiology
https://read.qxmd.com/read/38606791/molecular-and-pathophysiological-relationship-between-obesity-and-chronic-inflammation-in-the-manifestation-of-metabolic-dysfunctions-and-their-inflammation%C3%A2-mediating-treatment-options-review
#27
JOURNAL ARTICLE
Fani-Niki Varra, Michail Varras, Viktoria-Konstantina Varra, Panagiotis Theodosis-Nobelos
Obesity reaches up to epidemic proportions globally and increases the risk for a wide spectrum of co‑morbidities, including type‑2 diabetes mellitus (T2DM), hypertension, dyslipidemia, cardiovascular diseases, non‑alcoholic fatty liver disease, kidney diseases, respiratory disorders, sleep apnea, musculoskeletal disorders and osteoarthritis, subfertility, psychosocial problems and certain types of cancers. The underlying inflammatory mechanisms interconnecting obesity with metabolic dysfunction are not completely understood...
June 2024: Molecular Medicine Reports
https://read.qxmd.com/read/38605208/distinguishing-health-related-parameters-between-metabolically-healthy-and-metabolically-unhealthy-obesity-in-women
#28
JOURNAL ARTICLE
Fernando Mendonça, Pietra Soares, Telma Moreno, Paula Freitas, Ilda Rodrigues, Diana Festas, Jorge Pedro, Ana Varela, Ana Fernandes, Rúben Fernandes, Raquel Soares, Eduardo Lima Costa, Carla Luís
BACKGROUND: Obesity represents a global health crisis, yet a dichotomy is emerging with classification according to the metabolic state into metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO). This study aimed to identify distinctive systemic clinical/endocrinological parameters between MHO individuals, employing a comprehensive comparative analysis of 50 biomarkers. Our emphasis was on routine analytes, ensuring cost-effectiveness for widespread use in diagnosing metabolic health...
April 11, 2024: International Journal of Obesity
https://read.qxmd.com/read/38604416/a-review-regarding-the-article-diabetic-peripheral-neuropathy-is-associated-with-diabetic-kidney-disease-and-cardiovascular-disease-the-silesia-diabetes-heart-project
#29
REVIEW
Xuegui Ju, Bhushan Sandeep, Fang Liu
One of the most common micro vascular complications of diabetes is diabetic peripheral neuropathy (DPN). The well-recognized risk factors for DPN are hyperglycemia, dyslipidemia, and hypertension. DPN is associated with a high mortality rate and poor prognosis. Its pathogenesis is not fully understood, and clinical treatment is focused on relieving its clinical symptoms, as well as improving blood sugar control and cardiovascular risk factors. DPN and its clinically effective treatments need to be studied. Microvascular complications of diabetes present a significant challenge due to their diverse presentations, significant morbidity, and as strong predictors of cardiovascular disease...
April 9, 2024: Current Problems in Cardiology
https://read.qxmd.com/read/38603585/insulin-resistance-related-cardiometabolic-risk-among-nondiabetic-childbearing-age-females
#30
JOURNAL ARTICLE
Nawoda Hewage, Udaya Wijesekara, Rasika Perera
Background: This study evaluates insulin resistance prevalence in young females without diabetes, assessing risk factors and adiposity indices for early detection of cardiometabolic disorders. Methods: A cross-sectional study was conducted, involving 282 females aged 18-35 years from suburban and rural areas of Sri Lanka. Anthropometric measurements [height, weight, waist circumference (WC)] were obtained and biochemical parameters [fasting glucose, insulin, insulin resistance (IR), total cholesterol, high-density lipoproteins, (HDL), low-density lipoproteins, triglycerides] were measured...
April 11, 2024: Metabolic Syndrome and related Disorders
https://read.qxmd.com/read/38603555/therapeutic-effects-of-amaranth-analysis-of-the-antidiabetic-potential-of-the-plant
#31
REVIEW
Andrea Campos Herrera, Francisco Valenzuela Zamudio, Maira Rubi Segura Campos
Amaranth is a pseudocereal rich in macronutrients and micronutrients, with about 60 species cultivated worldwide. It is a high nutritional value food because of its many essential amino acids. Recent investigations demonstrate that the phytochemicals and extracts of amaranth have beneficial effects on health, including antidiabetic potential, a decrease in plasmatic cholesterol and blood pressure, and protection from oxidative stress and inflammation. Nowadays, type 2 diabetes has increased worldwide, becoming a problem of public health that makes it necessary to look for alternative strategies for its prevention and treatment...
April 2024: Journal of Medicinal Food
https://read.qxmd.com/read/38599878/increased-risk-of-cardiovascular-and-renal-disease-and-diabetes-for-all-women-diagnosed-with-gestational-diabetes-mellitus-in-new-zealand-a-national-retrospective-cohort-study
#32
JOURNAL ARTICLE
Barbara M Daly, Zhenqiang Wu, Krishnarajah Nirantharakumar, Lynne Chepulis, Janet A Rowan, Robert K R Scragg
BACKGROUND: Gestational diabetes mellitus increases the risk of developing type 2 diabetes. The aim of this study is to compare cardiometabolic and renal outcomes for all women in New Zealand with gestational diabetes (2001-2010) with women without diabetes, 10-20 years following delivery. METHODS: A retrospective cohort study, utilizing a national dataset providing information for all women who gave birth between 1 January 2001 and 31 December 2010 (n = 604 398)...
April 2024: Journal of Diabetes
https://read.qxmd.com/read/38599293/development-and-evaluation-of-a-prediction-model-for-peripheral-artery-disease-related-major-adverse-limb-events-using-novel-biomarker-data
#33
JOURNAL ARTICLE
Ben Li, Rakan Nassereldine, Abdelrahman Zamzam, Muzammil H Syed, Muhammad Mamdani, Mohammed Al-Omran, Rawand Abdin, Mohammad Qadura
BACKGROUND: Prognostic tools for individuals with peripheral artery disease (PAD) remain limited. We developed prediction models for 3-year PAD related major adverse limb events (MALE) using demographic, clinical, and biomarker data previously validated by our group. METHODS: We performed a prognostic study using a prospectively recruited cohort of PAD patients (n = 569). Demographic/clinical data were recorded including sex, age, comorbidities, previous procedures, and medications...
April 8, 2024: Journal of Vascular Surgery
https://read.qxmd.com/read/38597552/testosterone-deficiency-in-hypertensive-men-prevalence-and-associated-factors
#34
JOURNAL ARTICLE
Leandra Analia Freitas Negretto, Nelson Rassi, Leonardo Ribeiro Soares, Amanda Bueno Carvalho Saraiva, Maria Emília Figueiredo Teixeira, Luciana da Ressurreição Santos, Ana Luiza Lima Souza, Paulo Cesar B Veiga Jardim, Weimar Kunz Sebba Barroso de Souza, Thiago de Souza Veiga Jardim
BACKGROUND: Testosterone deficiency (TD) is a prevalent condition in our midst and still very neglected. Arterial hypertension (AH) is one of the possible associated factors. OBJECTIVES: To determine the prevalence of TD in a hypertensive male population and the factors associated with its occurrence, such as age, time since hypertension diagnosis, number of antihypertensive classes, body mass index (BMI), diabetes, dyslipidemia, chronic kidney disease (CKD), positive symptoms of TD (positive ADAM questionnaire) and use of spironolactone...
2024: Arquivos Brasileiros de Cardiologia
https://read.qxmd.com/read/38596005/the-association-between-physical-activities-combined-with-dietary-habits-and-cardiovascular-risk-factors
#35
JOURNAL ARTICLE
Weiwei Wang, Hairong Zhou, Shengxiang Qi, Huafeng Yang, Xin Hong
OBJECTIVES: The aim of this study was to investigate the association between physical activities combined with dietary habits and cardiovascular risk factors in adults from Nanjing, China. METHODS: The cross-sectional survey conducted in 2017 involved a sample of 60 283 individuals aged ≥18 years in Nanjing municipality, China. The sampling method used was multistage stratified cluster sampling. The primary outcomes from multivariate logistic regression analysis with adjusted potential confounders were the relationships between physical activities combined with dietary habits and cardiovascular risk variables...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38594474/mafld-as-part-of-systemic-metabolic-dysregulation
#36
JOURNAL ARTICLE
Jing Zhao, Lu Liu, Ying-Ying Cao, Xin Gao, Giovanni Targher, Christopher D Byrne, Dan-Qin Sun, Ming-Hua Zheng
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. In recent years, a new terminology and definition of metabolic dysfunction-associated fatty liver disease (MAFLD) has been proposed. Compared to the NAFLD definition, MAFLD better emphasizes the pathogenic role of metabolic dysfunction in the development and progression of this highly prevalent condition. Metabolic disorders, including overweight/obesity, type 2 diabetes mellitus (T2DM), atherogenic dyslipidemia and hypertension, are often associated with systemic organ dysfunctions, thereby suggesting that multiple organ damage can occur in MAFLD...
April 9, 2024: Hepatology International
https://read.qxmd.com/read/38592640/psoriasis-and-molecular-target-therapies-evidence-of-efficacy-in-preventing-cardiovascular-comorbidities
#37
REVIEW
Luca Potestio, Nello Tommasino, Giuseppe Lauletta, Fabrizio Martora, Matteo Megna
Psoriasis is now considered a systemic disease, and several comorbidities have been described such as cardiovascular diseases, neurologic and psychiatric disorders, chronic inflammatory bowel disease, psoriatic arthritis, etc. Regarding cardiovascular comorbidities, major adverse cardiovascular events have been reported in psoriasis patients by multiple epidemiologic studies. Moreover, smoking, obesity, metabolic syndrome, hypertension, dyslipidemia, diabetes and reduced physical activity are associated with psoriasis, increasing cardiovascular risk...
April 9, 2024: Dermatology and Therapy
https://read.qxmd.com/read/38592226/cognitive-impairment-and-brain-atrophy-in-patients-with-chronic-kidney-disease
#38
REVIEW
Kazuhiko Tsuruya, Hisako Yoshida
In Japan, the aging of the population is rapidly accelerating, with an increase in patients with chronic kidney disease (CKD) and those undergoing dialysis. As a result, the number of individuals with cognitive impairment (CI) is rising, and addressing this issue has become an urgent problem. A notable feature of dementia in CKD patients is the high frequency of vascular dementia, making its prevention through the management of classical risk factors such as hypertension, diabetes mellitus, dyslipidemia, smoking, etc...
February 28, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38590698/the-impact-of-dyslipidemia-on-prognosis-of-patients-after-endovascular-abdominal-aortic-aneurysm-repair
#39
JOURNAL ARTICLE
Xin Luo, Qiang Guo, Jiarong Wang, Yiyuan Li, Jichun Zhao, Bin Huang, Xiyang Chen
INTRODUCTION: Dyslipidemia is common in patients with abdominal aortic aneurysm (AAA). However, there is insufficient research on the impact of dyslipidemia on the postoperative outcomes of patients with AAA after endovascular aortic aneurysm repair (EVAR). This study aimed to determine the impact of dyslipidemia on the prognosis of patients with AAA treated with EVAR. METHOD: We retrospectively reviewed patients with AAA who underwent EVAR at our hospital between 2010 and 2020...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38590611/the-prevalence-of-cardiovascular-diseases-chronic-kidney-disease-and-obesity-in-patients-with-type-2-diabetes-mellitus-and-the-description-of-concurrent-treatments-a-two-center-retrospective-cross-sectional-study-in-saudi-arabia
#40
JOURNAL ARTICLE
Omar A Alshaya, Ghazwa B Korayem, Munirah Alghwainm, Wed Alyami, Albandari Alotaibi, Majed S Alyami, Omar A Almohammed
BACKGROUND: Atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), chronic kidney disease (CKD), and obesity are associated with increased morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). Nonetheless, their prevalence among patients with T2DM in Saudi Arabia (SA) remains unknown. As current guidelines recommend, these comorbidities require adding certain antidiabetic agents with cardiorenal benefits. However, the prescribers' adherence to these recommendations remains unclear...
May 2024: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
keyword
keyword
21390
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.